EROX — Human Pheromone Sciences Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Human Pheromone Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2006 December 31st	2007 December 31st	2008 December 31st	2009 December 31st	2010 December 31st
Period Length:	—	—	—	—	—
Source:	10KSB	10KSB	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.94	1.44	0.907	0.35	0.092
Net Total Accounts Receivable
Net Total Receivables	0.039	0.194	0.052	0.141	0.108
Total Inventory
Total Other Current Assets
Total Current Assets	2.07	1.7	1.06	0.589	0.275
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.003	0.002	0.001	0
Total Assets	2.08	1.7	1.06	0.59	0.275
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.99	0.687	0.447	0.389	0.289
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.71	1.25	0.771	0.547	0.313
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	0.364	0.446	0.287	0.043	-0.039
Total Liabilities & Shareholders' Equity	2.08	1.7	1.06	0.59	0.274
Total Common Shares Outstanding